Cargando…
Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications
Autores principales: | Hajifathalian, Kaveh, Krisko, Tibor, Mehta, Amit, Kumar, Sonal, Schwartz, Robert, Fortune, Brett, Sharaiha, Reem Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205652/ https://www.ncbi.nlm.nih.gov/pubmed/32389667 http://dx.doi.org/10.1053/j.gastro.2020.05.010 |
Ejemplares similares
-
SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant
por: Hajifathalian, Kaveh, et al.
Publicado: (2020) -
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease
por: Lukin, Dana J., et al.
Publicado: (2020) -
Sal11 CONVERSION RATE FOR COVID19 IN NEW YORK CITY: IMPACT OF SOCIAL DISTANCING AND UNIVERSAL MASKING
por: Hajifathalian, Kaveh, et al.
Publicado: (2021) -
Effect of the Coronavirus 2019 Pandemic on Outcomes for Patients Admitted With Gastrointestinal Bleeding in New York City
por: Kim, Judith, et al.
Publicado: (2020) -
Observed risk of recurrent bleeding and thromboembolic disease in COVID-19 patients with gastrointestinal bleeding
por: Attah, Emmanuel, et al.
Publicado: (2021)